Patients with a personal or family history of medullary thyroid carcinoma or patients with Multiple Endocrine Neoplasia syndrome type 2
Patients with a prior serious hypersensitivity reaction to liraglutide
Other contra-indications to liraglutide in accordance with risks and safety information included in the latest updated prescribing information
Type 1 diabetes, as defined by ADA criteria
Current use of other GLP-1A, dipeptidyl peptidase 4 (DPP4) or Sodium Glucose transporters 2 (SGLT2) inhibitors, thiazolidinediones (TZDs), pramlintide and fixed prandial insulin.
Patients with unstable CAD, assessed by the Cardiology team and defined as new onset angina, rest angina, rapidly increasing or crescendo angina
History of diabetic ketoacidosis, pancreas or beta-cell transplantation, or diabetes secondary to pancreatitis or pancreatectomy; acute or chronic infective diseases, cancer or chemotherapy, history of pulmonary, renal or liver diseases, and drug abuse
Patients with chronic and acute inflammatory conditions such as sepsis, rheumatoid arthritis, ectopic dermatitis, asthma, ulcerative colitis.
Current use of systemic corticosteroids in the 3 months prior this study.
Pregnant or breast-feeding women
Females of childbearing potential who are not using adequate contraceptive methods (as required by local law or practice)

NCT03260881_exc_T1
Observation
personal history
NCT03260881_exc_T2
Observation
family history
NCT03260881_exc_T3
Condition
medullary thyroid carcinoma
NCT03260881_exc_T4
Condition
Multiple Endocrine Neoplasia syndrome type 2
NCT03260881_exc_T5
Scope
personal or family history
NCT03260881_exc_T6
Scope
medullary thyroid carcinoma or patients with Multiple Endocrine Neoplasia syndrome type 2
NCT03260881_exc_T7
Condition
hypersensitivity reaction
NCT03260881_exc_T8
Drug
liraglutide
NCT03260881_exc_T9
Temporal
prior
NCT03260881_exc_T10
Qualifier
serious
NCT03260881_exc_T11
Drug
liraglutide
NCT03260881_exc_T12
Condition
contra-indications
NCT03260881_exc_T13
Qualifier
Other
NCT03260881_exc_T14
Condition
Type 1 diabetes
NCT03260881_exc_T15
Qualifier
ADA criteria
NCT03260881_exc_T16
Drug
GLP-1A
NCT03260881_exc_T17
Qualifier
other
NCT03260881_exc_T18
Drug
ptidyl peptidase 4 (DPP4) or bitors, th
NCT03260881_exc_T19
Drug
Sodium Glucose transporters 2 (SGLT2) inhibitors
NCT03260881_exc_T20
Drug
thiazolidinediones (TZDs)
NCT03260881_exc_T21
Drug
pramlintide
NCT03260881_exc_T22
Drug
prandial insulin
NCT03260881_exc_T23
Condition
unstable CAD
NCT03260881_exc_T24
Condition
new onset angina
NCT03260881_exc_T25
Condition
rest angina
NCT03260881_exc_T26
Condition
ly increasing or c a
Hist
NCT03260881_exc_T27
Condition
crescendo angina
NCT03260881_exc_T28
Scope
new onset angina, rest angina, rapidly increasing or crescendo angina
NCT03260881_exc_T29
Condition
diabetic ketoacidosis
NCT03260881_exc_T30
Procedure
as or be lantation, or d
NCT03260881_exc_T31
Procedure
beta-cell transplantation
NCT03260881_exc_T32
Condition
diabetes
NCT03260881_exc_T33
Procedure
pancreatitis
NCT03260881_exc_T34
Procedure
pancreatectomy
NCT03260881_exc_T35
Scope
pancreatitis or pancreatectomy
NCT03260881_exc_T36
Qualifier
secondary to
NCT03260881_exc_T37
Qualifier
acute
NCT03260881_exc_T38
Qualifier
chronic
NCT03260881_exc_T39
Condition
infective diseases
NCT03260881_exc_T40
Condition
cancer
NCT03260881_exc_T41
Procedure
chemotherapy
NCT03260881_exc_T42
Condition
liver diseases
NCT03260881_exc_T43
Condition
or li es, and
NCT03260881_exc_T44
Condition
ary, rena es, and
NCT03260881_exc_T45
Condition
drug abuse
NCT03260881_exc_T46
Scope
acute or chronic
NCT03260881_exc_T47
Observation
History
NCT03260881_exc_T48
Scope
diabetic ketoacidosis, pancreas or beta-cell transplantation, or diabetes secondary to pancreatitis or pancreatectomy; acute or chronic infective diseases, cancer or chemotherapy, history of pulmonary, renal or liver diseases, and drug abuse
NCT03260881_exc_T49
Qualifier
chronic
NCT03260881_exc_T50
Qualifier
acute
NCT03260881_exc_T51
Condition
inflammatory conditions
NCT03260881_exc_T52
Condition
sepsis
NCT03260881_exc_T53
Condition
rheumatoid arthritis
NCT03260881_exc_T54
Condition
ectopic dermatitis
NCT03260881_exc_T55
Condition
asthma
NCT03260881_exc_T56
Condition
ulcerative colitis
NCT03260881_exc_T57
Scope
sepsis, rheumatoid arthritis, ectopic dermatitis, asthma, ulcerative colitis
NCT03260881_exc_T58
Scope
chronic and acute
NCT03260881_exc_T59
Temporal
Current
NCT03260881_exc_T60
Drug
systemic corticosteroids
NCT03260881_exc_T61
Temporal
in the 3 months prior this study
NCT03260881_exc_T62
Condition
Pregnant
NCT03260881_exc_T63
Condition
breast-feeding women